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OF THE two types of retroviruses that have been isolated in pallents with acquired Immunodeficiency 
syndrome (AIDS). human Immunodeficiency Virus-I 
(H IV -I) is the more common in the United States. Europe. 
and Central Africa. Very few monkeys have been success-
fully infected with HIV -I. including chimpanzee and gib-
bon apes. Some of the moculated animals have developed 
high titer virus-specific antibody responses after infection. 
However. no ammal has developed the disease. I Gener-
ally. small animal species. such as rodents. are even more 
resistant to AIDS and are not susceptible to HIV infection 
through nonnal routes. 2 The spread of AIDS and HIV 
infecllon has become a global concern and the search for" 
cure has been hampered by the lack of SUitable animal 
models. 
We propose to consider these "negallve results" in the 
development of suitable animal models as a potential clue 
for the treatment. that is. to verify whether hematopoietic 
cells from a donor that does not develop AIDS can transfer 
disease resistance to an infected recipient. If patients with 
AIDS could be successfully transplanted with xenogeneic 
bone marrow cells (BMO from a resistant species. a 
gradual replacement of the dying lymphoid cells of the 
recipient could occur. with BMC from the resistant donor 
that could selectively survive. 3 We report the first attempt 
to verify this hypothesis by reconstitution of an AIDS 
patient with xenogeneic bone malTow from a resistant 
species. the baboon. 
PATIENT AND METHODS 
The recipient was an HIV-positive. 56-year-old male with ad-
vanced AIDS (pancytopema. malnutrition. dehydration. meta-
bolic acidosis. chronic CryplOsporidium diarrhea). Lymphocyto-
toxicity cross-match was strongly positive (titer 1:2; DTT 
negative). Cross-matching of patient serum against baboon red 
blood cells (RBCs) indicated a human antibaboon heteroagglutinin 
liter of 1:4 (room temperature) and I :32 (Coombs phase). The 
donor bone marrow was depleted of RBCs resulting in a loss of 
BMC from 30 x 109 before. to 6.6 x 10" after depletion. The final 
dose of BMC infused was 0.94 x 1000lkg BMC. comprising 0.48 x 
1000lkg CD4- cells. Immunosuppression was with FK-506. Cy-
toxan. PGE-I. and steroids. Primers recognizing the chorionic 
gonadotropin gene of the baboon were used for amplification 
followed by Southern blot to detect baboon DNA in the recipient 
at different urnes after transplantauon. H IV titer was measured by 
quantitauve microcultures performed following senal dilutions 
PBMC that were co-cultured with I x lOb stimulated normal 
PBMC. FollOWing culture for 21 days. virus production was 
measured by p24 assay in culture supernatants. 
RESULTS AND DISCUSSION 
Xenogeneic BMC infusion was well tolerated by the pa-
lIent and did not produce any early complication such a~ 
anaphylaxis or graft-versus-host disease. However. nll 
significant change was observed in circulating CD4 levels. 
CD4/CDH ratio. and cell-aSSOCiated HIV titer during the 
follow-up (Table Il. Polymerase chain reaCllon (PCR) 
results were negative for baboon DNA at 3 to 47 days. The 
patient was discharged 53 days posttransplant and eventu-
ally died 2 weeks later of progressive disease. The results 
indicated that the baboon BMC failed to engraft. How-
ever. xenogeneic BMC infUSIOn did not produce early 
complicatIOns. Without evidence for xenogeneic BMC 
engraftment. it was not possible to determine the potenti,,1 
of this approach to treat AIDS. We have recent evidence 
that chimensm can be obtained by BMC xenotransplanta-
tion across these species. Two baboons that were treated 
with a single dose of total lymphoid irradiation (TLI. 750 
Gy) before receiving a human bone malTow infusion. were 
positive for human DNA (PCR) over 6 months following 
xenotransplantation. The animals did not receive any 
additional immunosuppressive treatment following the sin-
gle dose of TLI (P. Fontes et a!. manuscript in prepara-
tion). In addition. we have recently infused baboon bone 
malTow in a patient who received a liver transplant from 
the same donorK~ In this case. the baboon bone malTow 
was not treated to remove RBCs and baboon DNA wa~ 
detected during the follow-up. indicating that a state of 
Table 1. 
PntIrenapiant Day 7 Day 15 Day 28 
wec count 3.5 3.6 6.4 5.9 
Lymph 210 72 256 1n 
CD4(%) 2(1) 4(5) 15(6) TFTC 
CD4ICDB 0.03 0.06 0.1 TFTC 
HIV titer 4 256 <1 
AIlbnMaIlOnS: weC. whne DIOocI cell; HIV. human ImmunoclellCllltlCY YltUS; 
TFTC. 100 lew to count 
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microchill'leril8t wu eItahIJshod. HOWPW, it oa1IDOC be 
t.XCIIuded tMt &b. daaoI- IiYw WU IUpOIIliblv fix" tbc 
~ c::bbucrk .... bec:aUM it is lOW IaIoWD UIar 
cldlDeltlmu prat1I& ill RIdpieDU of myorpa~K 4 
FIDtber SIIIdieI are aeedecl to detenaine tbe ideal cicaar 
s:peciu tbII c::auId he used for hem'" ",,!jo!OO recaastitution 
of padeIa wi1h AIDS. aDd the ideal induction aDdIar 
immuIIuIuppn:1Ive UUUIIIJM 10 CISlIbllSlla chJmeric Stile 
in &be recipieDU. 
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